Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry

The AGAMENON registry suggests that subjects with limited metastatic disease, selected on a clinical basis, can benefit from early surgeries. Prospective trials are needed to confirm these data.